Abiopharma

Clinical trial NCT07201051: enrollment: 446 → 363 participants.

Clinical trial NCT06982235: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT04204252 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2031-06-01 → 2026-02-27 3. primary completion date: 2028-12-01 → 2026-02-19 4. enrollment: 220 → 98 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06998121: primary completion date: 2026-03-19 → 2026-04-15.

Clinical trial NCT07021989 updates: 1. start date: 2026-07-01 → 2026-10-01 2. completion date: 2033-12-31 → 2034-03-31 3. primary completion date: 2029-05-31 → 2029-07-31

Clinical trial NCT06263543 updates: 1. completion date: 2026-12-01 → 2028-12-01 2. primary completion date: 2026-06-01 → 2028-06-01

Clinical trial NCT06451614: primary completion date: 2026-07-30 → 2026-08-30.

Clinical trial NCT07621003: start date: 2026-07-01 → 2026-08-17.

Clinical trial NCT06139211 updates: 1. status: RECRUITING → COMPLETED 2. start date: 2024-01-03 → 2023-12-06 3. completion date: 2026-01-28 → 2026-05-28 4. primary completion date: 2025-11-01 → 2026-05-28 5. enrollment: 186 → 66 participants 6. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07556588: start date: 2026-04-15 → 2024-08-03.